Akers Biosciences, Inc.

129 articles about Akers Biosciences, Inc.

• Akers Biosciences Completes Clinical Trial For Rapid Chlamydia Test

  7/1/2016

• Akers Biosciences Signs Distribution Agreement For BreathScan OxiChek

  6/28/2016

• Akers Biosciences Signs Deal for Breathscan Oxichek

  6/27/2016

• Akers Biosciences To Present At LD Micro Invitational Conference

  6/6/2016

• Akers Biosciences Reports Earnings For Q1 2016

  5/13/2016

• Akers Biosciences Announces Conference Call To Discuss Q1 2016 Earnings

  5/11/2016

• Akers Biosciences To Present At "Pioneers 2016" Investor Conference

  5/5/2016

• Akers Biosciences Board Rearrangement

  5/2/2016

• Akers Biosciences Reports Earnings For Fiscal Year 2015

  3/31/2016

• Akers Biosciences Allowed U.S. Patent For Heparin/PF4 Antibody Detection

  3/23/2016

• Akers Biosciences Announces Conference Call To Discuss Its 2015 Earnings

  3/17/2016

• Akers Biosciences Announces $2.5M Order To Supply PIFA Heparin/PF4 Products To China

  3/2/2016

• Akers Biosciences Hires Leading Commercial Executives To Support Sales Growth

  2/29/2016

• Akers Biosciences Updates On Joint Venture In China

  12/1/2015

• Akers Biosciences To Present At 8th Annual LD Micro Investor Conference

  11/30/2015

• Akers Biosciences Taps Industry Vet as New CEO

  11/23/2015

• Akers Biosciences, Inc. Announces Q3 2015 Earnings

  11/13/2015

• Akers Biosciences, Inc. Appoints Dr. Raza Bokhari As Non-Executive Director

  11/12/2015

• Akers Biosciences, Inc. Announces Conference Call To Discuss Its Third Quarter 2015 Earnings

  11/11/2015

• Akers Biosciences, Inc.' Flagship Test For Heparin-Induced Thrombocytopenia Granted Approval By Chinese Food And Drug Administration

  11/4/2015